HPV Vaccine Information for Clinicians – Fact Sheet
Human papillomavirus (HPV) is the most common sexually transmitted infection and is associated with many types of cancers that disproportionately impact Hispanics. An HPV vaccine is available for individuals ages 9—45 that can prevent up to 90% of HPV-a
[8]CDC.Genital HPV Infection – Basic Fact Sheet. https://www.cdc.gov/std/hpv/stdfact-hpv.htm#print. [9]Human Papillomavirus: A Hidden Epidemic in the United States. https://www.prb.org/resources/human-papillomavirus-a-hidden-epidemic-in-the-united-states/. [10]Chesson HW, Dunne EF,...
Genotypes that are still non-vaccine-targeted were detected in 17.98% of the women, but these were not significantly associated with high-grade lesions. Conclusion The greater protection of the nine-valent HPV vaccine is likely to have a positive impact because, in the absence of genotype 16 ...
17. Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012 Nov 20;30 Suppl 5(0 5):F123-381. 18. 九价人乳头瘤病毒疫苗(酿酒酵母)说明书 19. 四价人乳头瘤病毒...
PDS0101 is a type of vaccine that is intended to help the immune system respond to human papillomavirus (HPV16)-infected cervical tumor cells. PDS0101 contains two active components: the first is called R-DOTAP (Versamune) and is included in the vaccine to boost the immune system's response...
Human Papilloma Virus ( HPV ) VaccineFactsheet, Cancer Information
Since the introduction of HPV vaccines, several studies have been conducted in different countries to assess HPV knowledge and vaccine acceptance. The aim of this study was to perform a systematic literature review to summarize results and identify factors associated with HPV knowledge and vaccine acce...